The breast cancer screening tests market is projected to grow from USD 2.4 billion in 2025 to USD 5.0 billion by 2035, at a CAGR of 7.4%. Imaging Test will dominate with a 30.0% market share, while hospitals will lead the end user segment with a 40.0% share.